首页 > 最新文献

Clinica e Investigacion en Ginecologia y Obstetricia最新文献

英文 中文
A survey of female sexual dysfunction in gynaecological cancer survivors: A case–control study 癌症妇科幸存者女性性功能障碍的调查:一项病例对照研究
IF 0.1 Q4 Medicine Pub Date : 2023-07-01 DOI: 10.1016/j.gine.2022.100826
M. Arab , N. Poorzad , G. Noghabaei , B. Ghavami , B. Nouri , T. Jahed Bozorgan

Background

With diagnostic and treatment advancements in cancer management, the need for improvement of survivors’ quality of life has been increasing. One of the issues affecting the quality of life in gynecologic cancer survivors is a decline in their sexual function, which is affected in many ways. In order to assess sexual dysfunction in gynecologic cancer survivors.

Objective

This study is designed to assess different areas of sexual function including desire, arousal, vaginal lubrication, orgasm, satisfaction, and pain.

Materials and methods

Patients who had completed treatment since 6 months to 6 years ago included in the case–control study starting from January 2019 to January 2020. Twenty-nine sexually active gynecologic cancer survivors with sexual dysfunction were enrolled as cases and 91 sexually active ones without sexual problems were assigned to the control group. The Female Sexual Function Index (FSFI) questionnaire consisting of 19-items and six areas was completed for each participant.

Results

Average sexual dysfunction score of the case group was 16.78 with cut-off point of 28 for dysfunction. The most common domain of sexual dysfunction was pain (96.55%), followed by sexual arousal (86.21%), vaginal lubrication (72.41%), orgasm (72.41%), satisfaction (65.52%) and sexual desire (55.17%).

Conclusion

In gynecologic cancer survivors, sexual dysfunction was directly related to employment, brachytherapy and co-existing DM and inversely related to the time elapsed since cancer diagnosis and menopause. Asking about sexual problems and referral to a specialist should be included in the patient treatment process.

背景随着癌症诊断和治疗管理的进步,提高幸存者生活质量的需求也在增加。影响妇科癌症幸存者生活质量的问题之一是他们的性功能下降,这在许多方面受到影响。为了评估妇科癌症幸存者的性功能障碍。目的本研究旨在评估性功能的不同领域,包括欲望、唤醒、阴道润滑、性高潮、满意度和疼痛。材料和方法自6个月至6年前完成治疗的患者纳入2019年1月至2020年1月的病例对照研究。20例性活跃的癌症妇科性功能障碍幸存者作为病例,91例性活跃且无性问题的幸存者被分配到对照组。每个参与者都完成了女性性功能指数(FSFI)问卷,该问卷由19个项目和6个领域组成。结果病例组性功能障碍的平均得分为16.78,功能障碍的分界点为28。性功能障碍最常见的领域是疼痛(96.55%),其次是性唤起(86.21%)、阴道润滑(72.41%)、性高潮(72.40%)、满意度(65.52%)和性欲(55.17%),近距离放射治疗和合并DM,并与癌症诊断和更年期后的时间呈负相关。询问性问题和转诊给专家应该包括在患者治疗过程中。
{"title":"A survey of female sexual dysfunction in gynaecological cancer survivors: A case–control study","authors":"M. Arab ,&nbsp;N. Poorzad ,&nbsp;G. Noghabaei ,&nbsp;B. Ghavami ,&nbsp;B. Nouri ,&nbsp;T. Jahed Bozorgan","doi":"10.1016/j.gine.2022.100826","DOIUrl":"https://doi.org/10.1016/j.gine.2022.100826","url":null,"abstract":"<div><h3>Background</h3><p>With diagnostic and treatment advancements in cancer management, the need for improvement of survivors’ quality of life has been increasing. One of the issues affecting the quality of life in gynecologic cancer survivors is a decline in their sexual function, which is affected in many ways. In order to assess sexual dysfunction in gynecologic cancer survivors.</p></div><div><h3>Objective</h3><p>This study is designed to assess different areas of sexual function including desire, arousal, vaginal lubrication, orgasm, satisfaction, and pain.</p></div><div><h3>Materials and methods</h3><p>Patients who had completed treatment since 6 months to 6 years ago included in the case–control study starting from January 2019 to January 2020. Twenty-nine sexually active gynecologic cancer survivors with sexual dysfunction were enrolled as cases and 91 sexually active ones without sexual problems were assigned to the control group. The Female Sexual Function Index (FSFI) questionnaire consisting of 19-items and six areas was completed for each participant.</p></div><div><h3>Results</h3><p>Average sexual dysfunction score of the case group was 16.78 with cut-off point of 28 for dysfunction. The most common domain of sexual dysfunction was pain (96.55%), followed by sexual arousal (86.21%), vaginal lubrication (72.41%), orgasm (72.41%), satisfaction (65.52%) and sexual desire (55.17%).</p></div><div><h3>Conclusion</h3><p>In gynecologic cancer survivors, sexual dysfunction was directly related to employment, brachytherapy and co-existing DM and inversely related to the time elapsed since cancer diagnosis and menopause. Asking about sexual problems and referral to a specialist should be included in the patient treatment process.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49832925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sclerosing stromal tumor of the ovary: Two case reports and literature review 卵巢硬化性间质瘤2例报告及文献复习
IF 0.1 Q4 Medicine Pub Date : 2023-07-01 DOI: 10.1016/j.gine.2023.100881
S. Tameish

Introduction

Sclerosing stromal tumors (SSTs) are rare benign ovarian tumors. They represent 6% of sex cord stromal tumors. Its preoperative diagnosis is often a challenge due to its similarity to malignant tumors on ultrasound imaging. We present two cases of SSTs to emphasize the consideration of this type of tumors in the differential diagnosis of solid adnexal masses in young women. A review of the literature on the typical ultrasound features, clinical presentation, and management of SSTs was performed.

Main symptoms and/or clinical findings

Pelvic pain was the main symptom in both cases. In the first case, transvaginal ultrasound revealed an unilocular solid adnexal mass of 59 mm × 44 mm × 45 mm with cystic areas and marked peripheral and central vascularization. MRI (magnetic resonance imaging) revealed a 50 mm × 50 mm heterogeneous adnexal mass with a solid peripheral component and a cystic-necrotic center. In the second case, pelvic ultrasound showed a solid cystic adnexal mass of 103 mm × 77 mm with marked peripheral vascularity.

Main diagnoses

Postoperative anatomopathological diagnosis in both cases was an ovarian SST.

Therapeutic interventions and results

Unilateral laparoscopic salpingo-oophorectomy and oophorectomy, respectively, was performed without incidents. There has been no recurrence during follow-up.

Conclusion

It is important to consider SSTs in the differential diagnosis of young women with a unilateral solid-cystic adnexal mass with a high degree of peripheral and central vascularization. Laparoscopic approach together with fertility-sparing techniques should be considered the treatment of choice.

引言硬化性间质瘤是一种罕见的卵巢良性肿瘤。它们占性脊髓间质瘤的6%。由于其在超声成像上与恶性肿瘤相似,术前诊断往往是一个挑战。我们报告了两例SSTs,以强调在年轻女性附件实性肿块的鉴别诊断中对这类肿瘤的考虑。对SST的典型超声特征、临床表现和治疗的文献进行了综述。主要症状和/或临床发现盆腔疼痛是两例患者的主要症状。在第一个病例中,经阴道超声显示一个59毫米×44毫米×45毫米的单眼实体附件肿块,伴有囊性区域和明显的外周和中心血管形成。MRI(磁共振成像)显示一个50 mm×50 mm的异质性附件肿块,具有固体外周成分和囊性坏死中心。在第二个病例中,盆腔超声显示103毫米×77毫米的实性囊性附件肿块,周围血管明显。主要诊断两例患者术后解剖病理诊断均为卵巢SST。治疗干预和结果:分别进行了单侧腹腔镜输卵管卵巢切除术和卵巢切除术,没有发生任何意外。随访期间没有复发。结论SSTs在青年女性单侧实性囊性附件肿块的鉴别诊断中具有重要意义,该肿块具有高度的外周和中心血管形成。腹腔镜入路和保留生育能力的技术应该被认为是治疗的选择。
{"title":"Sclerosing stromal tumor of the ovary: Two case reports and literature review","authors":"S. Tameish","doi":"10.1016/j.gine.2023.100881","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100881","url":null,"abstract":"<div><h3>Introduction</h3><p>Sclerosing stromal tumors (SSTs) are rare benign ovarian tumors. They represent 6% of sex cord stromal tumors. Its preoperative diagnosis is often a challenge due to its similarity to malignant tumors on ultrasound imaging. We present two cases of SSTs to emphasize the consideration of this type of tumors in the differential diagnosis of solid adnexal masses in young women. A review of the literature on the typical ultrasound features, clinical presentation, and management of SSTs was performed.</p></div><div><h3>Main symptoms and/or clinical findings</h3><p>Pelvic pain was the main symptom in both cases. In the first case, transvaginal ultrasound revealed an unilocular solid adnexal mass of 59<!--> <!-->mm<!--> <!-->×<!--> <!-->44<!--> <!-->mm<!--> <!-->×<!--> <!-->45<!--> <!-->mm with cystic areas and marked peripheral and central vascularization. MRI (magnetic resonance imaging) revealed a 50<!--> <!-->mm<!--> <!-->×<!--> <!-->50<!--> <!-->mm heterogeneous adnexal mass with a solid peripheral component and a cystic-necrotic center. In the second case, pelvic ultrasound showed a solid cystic adnexal mass of 103<!--> <!-->mm<!--> <!-->×<!--> <!-->77<!--> <!-->mm with marked peripheral vascularity.</p></div><div><h3>Main diagnoses</h3><p>Postoperative anatomopathological diagnosis in both cases was an ovarian SST.</p></div><div><h3>Therapeutic interventions and results</h3><p>Unilateral laparoscopic salpingo-oophorectomy and oophorectomy, respectively, was performed without incidents. There has been no recurrence during follow-up.</p></div><div><h3>Conclusion</h3><p>It is important to consider SSTs in the differential diagnosis of young women with a unilateral solid-cystic adnexal mass with a high degree of peripheral and central vascularization. Laparoscopic approach together with fertility-sparing techniques should be considered the treatment of choice.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49832928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Controversias en el tratamiento de la endometriosis en la mujer estéril 不孕妇女子宫内膜异位症治疗的争议
IF 0.1 Q4 Medicine Pub Date : 2023-07-01 DOI: 10.1016/j.gine.2023.100890
J. Gilabert-Estelles , L. Rodríguez-Tabernero

Endometriosis is a very complex disease that limits the lives of women who suffer from it in many areas of their lives, both due to the painful symptoms it causes and the medical complications it generates. In addition, it is capable of causing sterility by different mechanisms.

In the present work we intend to review the management of the patient with endometriosis and sterility, which has important particularities with respect to the usual treatment of endometriosis. Most of the medical treatments used have an anovulatory effect, which is why they prevent pregnancy, and surgical treatments can in turn have a detrimental effect on the ovarian reserve and the time necessary to achieve pregnancy. On the other hand, assisted reproduction techniques do not always achieve the desired objective and may require associated surgeries such as in the case of the presence of hydrosalpinx or ovaries not accessible to follicular puncture.

We also carried out a critical review of the medical literature and the guidelines of the different scientific societies to try to establish general criteria for the approach to these patients with endometriosis and sterility, who as a general rule should be treated by assisted reproductive techniques. A special analysis is made of the specific situations in which a differentiated approach with previous surgery is required when the function of a pelvic organ is in danger or in deep endometriosis.

子宫内膜异位症是一种非常复杂的疾病,由于其引起的疼痛症状和产生的医疗并发症,它限制了女性在生活的许多领域的生活。此外,它能够通过不同的机制引起不育。在目前的工作中,我们打算回顾子宫内膜异位症和不孕患者的管理,这与子宫内膜异位病的常规治疗有着重要的特殊性。大多数药物治疗都有无排卵作用,这就是为什么它们可以预防怀孕,而手术治疗反过来会对卵巢储备和怀孕所需的时间产生不利影响。另一方面,辅助生殖技术并不总是达到所需的目的,并且可能需要相关的手术,例如在存在输卵管积水或卵巢无法进行卵泡穿刺的情况下。我们还对医学文献和不同科学学会的指南进行了批判性审查,试图为这些子宫内膜异位症和不孕患者的治疗方法制定一般标准,这些患者通常应接受辅助生殖技术治疗。对骨盆器官功能处于危险或深度子宫内膜异位症中时需要与先前手术进行区分的具体情况进行了特别分析。
{"title":"Controversias en el tratamiento de la endometriosis en la mujer estéril","authors":"J. Gilabert-Estelles ,&nbsp;L. Rodríguez-Tabernero","doi":"10.1016/j.gine.2023.100890","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100890","url":null,"abstract":"<div><p>Endometriosis is a very complex disease that limits the lives of women who suffer from it in many areas of their lives, both due to the painful symptoms it causes and the medical complications it generates. In addition, it is capable of causing sterility by different mechanisms.</p><p>In the present work we intend to review the management of the patient with endometriosis and sterility, which has important particularities with respect to the usual treatment of endometriosis. Most of the medical treatments used have an anovulatory effect, which is why they prevent pregnancy, and surgical treatments can in turn have a detrimental effect on the ovarian reserve and the time necessary to achieve pregnancy. On the other hand, assisted reproduction techniques do not always achieve the desired objective and may require associated surgeries such as in the case of the presence of hydrosalpinx or ovaries not accessible to follicular puncture.</p><p>We also carried out a critical review of the medical literature and the guidelines of the different scientific societies to try to establish general criteria for the approach to these patients with endometriosis and sterility, who as a general rule should be treated by assisted reproductive techniques. A special analysis is made of the specific situations in which a differentiated approach with previous surgery is required when the function of a pelvic organ is in danger or in deep endometriosis.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49832933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nuevo paradigma en la cirugía del mioma: reparación uterina 肌瘤手术的新范式:子宫修复
IF 0.1 Q4 Medicine Pub Date : 2023-07-01 DOI: 10.1016/j.gine.2023.100859
Maria Luisa Cañete , Alicia Hernandez , Violeta Romero , Ignacio Lobo , Juan Luis Alcazar

Uterine fibroids are a frequent pathology that mainly affects women in their third and fourth decade of life. Most are asymptomatic. However, some may have a significant clinical impact or on the fertility of the patient. Recently there have been relevant changes in the diagnosis and management of this entity. This paper aims to summarize these changes discussed at the 1 st National Congress of the Spanish Society for the Study of Fibroids and Endometriosis.

子宫肌瘤是一种常见的病理学,主要影响生命第三和第四个十年的女性。大多数患者没有症状。然而,有些可能会对患者的临床或生育能力产生重大影响。最近,该实体的诊断和管理发生了相关变化。本文旨在总结西班牙纤维瘤和子宫内膜异位症研究学会第一届全国代表大会上讨论的这些变化。
{"title":"Nuevo paradigma en la cirugía del mioma: reparación uterina","authors":"Maria Luisa Cañete ,&nbsp;Alicia Hernandez ,&nbsp;Violeta Romero ,&nbsp;Ignacio Lobo ,&nbsp;Juan Luis Alcazar","doi":"10.1016/j.gine.2023.100859","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100859","url":null,"abstract":"<div><p>Uterine fibroids are a frequent pathology that mainly affects women in their third and fourth decade of life. Most are asymptomatic. However, some may have a significant clinical impact or on the fertility of the patient. Recently there have been relevant changes in the diagnosis and management of this entity. This paper aims to summarize these changes discussed at the 1 st National Congress of the Spanish Society for the Study of Fibroids and Endometriosis.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49832930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Niveles de vitamina D en sangre materna y su relación con el consumo de pescado y los parámetros antropométricos de los recién nacidos en una cohorte de parejas madre/hijos de Sevilla 塞维利亚母子夫妇队列中母亲血液中维生素D水平及其与鱼类消费和新生儿人体测量参数的关系
IF 0.1 Q4 Medicine Pub Date : 2023-07-01 DOI: 10.1016/j.gine.2023.100860
B. Dahiri , P. Carbonero-Aguilar , I. Martin-Carrasco , R. Carrillo , N. Florez , L. Cerrillos , R. Ostos , J. Bautista , I. Moreno

Introduction

To compare maternal vitamin D levels with the area of residence or the consumption of fish, as well as its relationship with the weight, length and cranial perimeter of babies.

Materials and methods

Cohort of 100 mother–child pairs (n = 100) from the province of Seville (Virgen del Rocío University Hospital and Valme University Hospital). In maternal blood samples (gestational age  40 weeks) 25(OH)D levels have been measured by chemiluminescence. Anthropometric measurements of the babies were made using standard methods.

Results

Regarding vitamin D levels, 54% had deficient values, 26% insufficient and 20% sufficient values. After a multiple regression analysis, it is observed that there is no significant difference between maternal vitamin D levels, the length and the cephalic perimeter of the babies, however, there is a difference with the birth weight (P < .05). When applying the t-Student and the Wilcoxon test, there is no relationship between vitamin D levels and the area of residence or with maternal fish consumption (both P > .05).

Conclusions

Eighty percent of mothers present deficient and insufficient values of vitamin D. There is no correlation between this parameter and the length and cephalic perimeter of the baby, observing a negative correlation with birth weight. No correlation was observed between the area of residence or the consumption of fish and vitamin D levels in mothers. We suggest dietary supplements for pregnant mothers and monitoring of vitamin D levels in babies.

引言比较母亲维生素D水平与居住面积或鱼类消费量的关系,以及与婴儿体重、身长和颅骨周长的关系。材料和方法来自塞维利亚省的100对母子(n=100)(Virgen del Rocío大学医院和Valme大学医院)。在母体血液样本(胎龄≥40周)中,通过化学发光测定了25(OH)D水平。使用标准方法对婴儿进行了人体测量。结果在维生素D水平方面,54%的人存在不足值,26%的人存在缺乏值,20%的人存在充足值。经过多元回归分析,观察到母亲的维生素D水平、婴儿的身长和头部周长之间没有显著差异,但与出生体重之间存在差异(P<;.05)。当应用t-Student和Wilcoxon检验时,维生素D水平与居住面积或母体鱼类消费量之间没有关系(均P>0.05)。没有观察到母亲的居住面积或鱼类消费量与维生素D水平之间的相关性。我们建议孕妇补充膳食,并监测婴儿体内的维生素D水平。
{"title":"Niveles de vitamina D en sangre materna y su relación con el consumo de pescado y los parámetros antropométricos de los recién nacidos en una cohorte de parejas madre/hijos de Sevilla","authors":"B. Dahiri ,&nbsp;P. Carbonero-Aguilar ,&nbsp;I. Martin-Carrasco ,&nbsp;R. Carrillo ,&nbsp;N. Florez ,&nbsp;L. Cerrillos ,&nbsp;R. Ostos ,&nbsp;J. Bautista ,&nbsp;I. Moreno","doi":"10.1016/j.gine.2023.100860","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100860","url":null,"abstract":"<div><h3>Introduction</h3><p>To compare maternal vitamin D levels with the area of residence or the consumption of fish, as well as its relationship with the weight, length and cranial perimeter of babies.</p></div><div><h3>Materials and methods</h3><p>Cohort of 100 mother–child pairs (<em>n</em> <!-->=<!--> <!-->100) from the province of Seville (Virgen del Rocío University Hospital and Valme University Hospital). In maternal blood samples (gestational age<!--> <!-->≥<!--> <!-->40 weeks) 25(OH)D levels have been measured by chemiluminescence. Anthropometric measurements of the babies were made using standard methods.</p></div><div><h3>Results</h3><p>Regarding vitamin D levels, 54% had deficient values, 26% insufficient and 20% sufficient values. After a multiple regression analysis, it is observed that there is no significant difference between maternal vitamin D levels, the length and the cephalic perimeter of the babies, however, there is a difference with the birth weight (<em>P</em> <!-->&lt;<!--> <!-->.05). When applying the <em>t</em>-Student and the Wilcoxon test, there is no relationship between vitamin D levels and the area of residence or with maternal fish consumption (both <em>P</em> <!-->&gt;<!--> <!-->.05).</p></div><div><h3>Conclusions</h3><p>Eighty percent of mothers present deficient and insufficient values of vitamin D. There is no correlation between this parameter and the length and cephalic perimeter of the baby, observing a negative correlation with birth weight. No correlation was observed between the area of residence or the consumption of fish and vitamin D levels in mothers. We suggest dietary supplements for pregnant mothers and monitoring of vitamin D levels in babies.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49832927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
El tratamiento hormonal es imperativo para todas las pacientes: lo antes posible y siempre 激素治疗对所有患者都至关重要:尽快并始终
IF 0.1 Q4 Medicine Pub Date : 2023-07-01 DOI: 10.1016/j.gine.2023.100856
M.Á. Martínez-Zamora

Endometriosis is nowadays considered an inflammatory chronic benign disease that responds to hormone manipulation and affects up to 10% of women in fertile age. It seems that innate or acquired changes in the endometrium ability to implant, invade and grow in an inflammatory milieu with estrogenic dependence and progesterone resistance are the responsible for new endometriosis implants and contribute to perpetuate the illness. There is, at the moment, no optimal known treatment that achieves the four basic objectives for the treatment of endometriosis: treat the symptoms, improve fertility, eliminate endometrial implants, and avoid illness progression. As is now considered a chronic condition, the prescribed medical treatment, until the patient arrives to the physiological menopause status or gets pregnant, must be considered in the long term, and must be effective and safe. Therefore, the realistic objectives of the treatment are the reduction or abolishment of symptoms and/or improve fertility. As a consequence of the limitations and risks of endometriosis surgeries, the first-line treatment is hormonal. This must be individualized according to age, parity, pregnancy desire, associated symptoms, other illnesses and patients preferences. Globally, there are two main types of first-line hormonal treatments: estroprogestins in extended or continuous regimens and some progestins in different routes of administration (dienogest, norethisterone acetate or desogestrel orally, and levonorgestrel high-dose intrauterine device). The different hormonal treatments and their pros and cons are explained in the manuscript.

如今,子宫内膜异位症被认为是一种炎症性慢性良性疾病,对激素操作有反应,影响高达10%的育龄妇女。子宫内膜在具有雌激素依赖性和孕激素抵抗的炎症环境中植入、侵袭和生长的能力的先天性或后天性变化似乎是新的子宫内膜异位症植入物的原因,并有助于使疾病长期存在。目前,还没有达到子宫内膜异位症治疗四个基本目标的最佳已知治疗方法:治疗症状、提高生育能力、消除子宫内膜植入物和避免疾病进展。由于现在被认为是一种慢性疾病,在患者达到生理更年期或怀孕之前,必须长期考虑处方治疗,并且必须有效和安全。因此,治疗的现实目标是减少或消除症状和/或提高生育能力。由于子宫内膜异位症手术的局限性和风险,一线治疗是激素治疗。这必须根据年龄、产次、怀孕意愿、相关症状、其他疾病和患者偏好进行个性化。在全球范围内,有两种主要类型的一线激素治疗:延长或连续方案中的雌孕激素和不同给药途径中的一些孕激素(双炔诺孕酮、醋酸炔诺酮或去氧孕烯口服和左炔诺孕酮高剂量宫内节育器)。手稿中解释了不同的激素治疗方法及其利弊。
{"title":"El tratamiento hormonal es imperativo para todas las pacientes: lo antes posible y siempre","authors":"M.Á. Martínez-Zamora","doi":"10.1016/j.gine.2023.100856","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100856","url":null,"abstract":"<div><p>Endometriosis is nowadays considered an inflammatory chronic benign disease that responds to hormone manipulation and affects up to 10% of women in fertile age. It seems that innate or acquired changes in the endometrium ability to implant, invade and grow in an inflammatory milieu with estrogenic dependence and progesterone resistance are the responsible for new endometriosis implants and contribute to perpetuate the illness. There is, at the moment, no optimal known treatment that achieves the four basic objectives for the treatment of endometriosis: treat the symptoms, improve fertility, eliminate endometrial implants, and avoid illness progression. As is now considered a chronic condition, the prescribed medical treatment, until the patient arrives to the physiological menopause status or gets pregnant, must be considered in the long term, and must be effective and safe. Therefore, the realistic objectives of the treatment are the reduction or abolishment of symptoms and/or improve fertility. As a consequence of the limitations and risks of endometriosis surgeries, the first-line treatment is hormonal. This must be individualized according to age, parity, pregnancy desire, associated symptoms, other illnesses and patients preferences. Globally, there are two main types of first-line hormonal treatments: estroprogestins in extended or continuous regimens and some progestins in different routes of administration (dienogest, norethisterone acetate or desogestrel orally, and levonorgestrel high-dose intrauterine device). The different hormonal treatments and their pros and cons are explained in the manuscript.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49832929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Controversias en el tratamiento de los miomas 肌瘤治疗的争议
IF 0.1 Q4 Medicine Pub Date : 2023-07-01 DOI: 10.1016/j.gine.2023.100854
M. Gracia , J. Isern Quitllet

Uterine fibroids are the most common tumours in women of reproductive age, but only 25% of women will require treatment due to the presence of symptoms. There are few randomised studies that have compared the different treatment options for uterine myoma; for the moment, surgery remains the option that offers the best rates of symptomatic resolution, improved quality of life, and a lower recurrence rate. Despite the widespread use of myoma surgery, it seems reasonable to believe that by reducing surgical treatments, either with less invasive therapies or with new medical treatments, both associated morbidity and costs would be reduced. In this sense, ablative techniques for myoma treatment, UAE, HIFU, and radiofrequency, have demonstrated results in terms of symptomatic control and quality of life comparable to surgery, with a low rate of major complications. Recurrence rates and the impact on patients’ future fertility would be the main concern. Future long-term comparative studies of ablative techniques and surgical approaches are needed.

子宫肌瘤是育龄妇女最常见的肿瘤,但只有25%的妇女因出现症状而需要治疗。很少有随机研究比较子宫肌瘤的不同治疗方案;目前,手术仍然是一种能提供最佳症状缓解率、改善生活质量和降低复发率的选择。尽管肌瘤手术得到了广泛应用,但似乎有理由相信,通过减少手术治疗,无论是微创治疗还是新的医疗治疗,相关的发病率和成本都会降低。从这个意义上说,子宫肌瘤治疗的消融技术,阿联酋,高强度聚焦超声和射频治疗,在症状控制和生活质量方面已经证明了与手术相当的效果,主要并发症发生率较低。复发率和对患者未来生育能力的影响将是主要关注的问题。未来需要对消融技术和手术方法进行长期的比较研究。
{"title":"Controversias en el tratamiento de los miomas","authors":"M. Gracia ,&nbsp;J. Isern Quitllet","doi":"10.1016/j.gine.2023.100854","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100854","url":null,"abstract":"<div><p>Uterine fibroids are the most common tumours in women of reproductive age, but only 25% of women will require treatment due to the presence of symptoms. There are few randomised studies that have compared the different treatment options for uterine myoma; for the moment, surgery remains the option that offers the best rates of symptomatic resolution, improved quality of life, and a lower recurrence rate. Despite the widespread use of myoma surgery, it seems reasonable to believe that by reducing surgical treatments, either with less invasive therapies or with new medical treatments, both associated morbidity and costs would be reduced. In this sense, ablative techniques for myoma treatment, UAE, HIFU, and radiofrequency, have demonstrated results in terms of symptomatic control and quality of life comparable to surgery, with a low rate of major complications. Recurrence rates and the impact on patients’ future fertility would be the main concern. Future long-term comparative studies of ablative techniques and surgical approaches are needed.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49870196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fallo ovárico, una problemática para las mujeres en edad reproductiva y su relación genética 卵巢衰竭,育龄妇女的一个问题及其遗传关系
IF 0.1 Q4 Medicine Pub Date : 2023-07-01 DOI: 10.1016/j.gine.2023.100849
L.I. Jaramillo Jaramillo, M.D. Roldan Tabares, S. Castañeda Palacio, L.M. Martínez-Sánchez

Primary ovarian failure is a condition in which women under 40 experience oligomenorrhea or amenorrhea for 4 months or longer; this early ovarian function loss may be related to a series of etiologies, including genetic disorders, autoimmune diseases, infections or iatrogenic causes; however 74%-90% are idiopathic. Despite being a less prevalent disorder, it is of great clinical importance since it affects all women in multiple aspects of life. At present, different studies are being developed in order to find new molecular targets to establish new therapies for the treatment of this pathology.

原发性卵巢功能衰竭是指40岁以下的女性出现月经过少或闭经4个月或更长时间的情况;这种早期卵巢功能丧失可能与一系列病因有关,包括遗传疾病、自身免疫性疾病、感染或医源性原因;而特发性占74%-90%。尽管它是一种不太常见的疾病,但它具有重要的临床意义,因为它影响到生活的多个方面的所有女性。目前,正在进行不同的研究,以寻找新的分子靶点,从而建立治疗这种病理的新疗法。
{"title":"Fallo ovárico, una problemática para las mujeres en edad reproductiva y su relación genética","authors":"L.I. Jaramillo Jaramillo,&nbsp;M.D. Roldan Tabares,&nbsp;S. Castañeda Palacio,&nbsp;L.M. Martínez-Sánchez","doi":"10.1016/j.gine.2023.100849","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100849","url":null,"abstract":"<div><p>Primary ovarian failure is a condition in which women under 40 experience oligomenorrhea or amenorrhea for 4<!--> <!-->months or longer; this early ovarian function loss may be related to a series of etiologies, including genetic disorders, autoimmune diseases, infections or iatrogenic causes; however 74%-90% are idiopathic. Despite being a less prevalent disorder, it is of great clinical importance since it affects all women in multiple aspects of life. At present, different studies are being developed in order to find new molecular targets to establish new therapies for the treatment of this pathology.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49870197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Manejo conservador con radioterapia e inmunoquimioterapia en el linfoma difuso de células B grandes primario de cuello uterino: Diagnóstico y tratamiento de una entidad rara 原发性大弥散性B细胞淋巴瘤放疗和免疫化疗的保守治疗:罕见实体的诊断和治疗
IF 0.1 Q4 Medicine Pub Date : 2023-07-01 DOI: 10.1016/j.gine.2023.100857
J.F. Robles Díaz

Introduction

Primary malignant cervical lymphoma is a very rare disease, which represents only 0.008% of all cervical tumors and 2% of all female extranodal lymphomas.

Main symptoms and/or clinical findings

The case of a 66-year-old woman from the Peruvian Andes is presented, with a disease period of 4 months characterized by gynaecorrhagia, with evidence of a 5 cm tumor cervix. Immunohistochemistry was performed on the biopsy of cervix to differentiate lymphoma from squamous cell carcinoma.

Primary diagnosis

Primary diffuse large B-cell lymphoma of the cervix with Ann Arbor IE IPI low-risk staging.

Therapeutic interventions and results

She being managed with immunochemotherapy (rituximab, cyclophosphamide, adriamycin, vincristine and prednisone), followed by consolidative external radiotherapy at a dose of 3,000 cGy in 15 sessions with a special IMRT technique. Resulting in satisfactory disease control and no complications from irradiation.

Conclusion

Primary diffuse large B-cell lymphoma of the cervix is very rare, therefore, in a case of primary stromal lesion of the cervix, suspicion of lymphoma should be taken into account.

引言原发性宫颈恶性淋巴瘤是一种非常罕见的疾病,仅占所有宫颈肿瘤的0.008%,占所有女性结外淋巴瘤的2%。主要症状和/或临床发现一例来自秘鲁安第斯山脉的66岁妇女,其发病期为4个月,以女性腐蚀症为特征,宫颈有5厘米的肿瘤。用免疫组织化学方法对宫颈活检进行淋巴瘤和鳞状细胞癌的鉴别。原发性诊断宫颈原发性弥漫性大B细胞淋巴瘤,采用Ann Arbor IE IPI低风险分期。治疗干预和结果通过免疫化疗(利妥昔单抗、环磷酰胺、阿霉素、长春新碱和泼尼松)进行治疗,然后用特殊的IMRT技术在15个疗程内进行3000 cGy剂量的巩固性外部放射治疗。结果得到了令人满意的疾病控制,并且没有放射并发症。结论原发性宫颈弥漫性大B细胞淋巴瘤非常罕见,因此,在原发性子宫颈间质病变的病例中,应考虑淋巴瘤的怀疑。
{"title":"Manejo conservador con radioterapia e inmunoquimioterapia en el linfoma difuso de células B grandes primario de cuello uterino: Diagnóstico y tratamiento de una entidad rara","authors":"J.F. Robles Díaz","doi":"10.1016/j.gine.2023.100857","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100857","url":null,"abstract":"<div><h3>Introduction</h3><p>Primary malignant cervical lymphoma is a very rare disease, which represents only 0.008% of all cervical tumors and 2% of all female extranodal lymphomas.</p></div><div><h3>Main symptoms and/or clinical findings</h3><p>The case of a 66-year-old woman from the Peruvian Andes is presented, with a disease period of 4 months characterized by gynaecorrhagia, with evidence of a 5<!--> <!-->cm tumor cervix. Immunohistochemistry was performed on the biopsy of cervix to differentiate lymphoma from squamous cell carcinoma.</p></div><div><h3>Primary diagnosis</h3><p>Primary diffuse large B-cell lymphoma of the cervix with Ann Arbor IE IPI low-risk staging.</p></div><div><h3>Therapeutic interventions and results</h3><p>She being managed with immunochemotherapy (rituximab, cyclophosphamide, adriamycin, vincristine and prednisone), followed by consolidative external radiotherapy at a dose of 3,000<!--> <!-->cGy in 15 sessions with a special IMRT technique. Resulting in satisfactory disease control and no complications from irradiation.</p></div><div><h3>Conclusion</h3><p>Primary diffuse large B-cell lymphoma of the cervix is very rare, therefore, in a case of primary stromal lesion of the cervix, suspicion of lymphoma should be taken into account.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49870558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concept of opportunistic bilateral salpingectomy in a sample of Mexican gynecologists. What should residents be trained on? 机会性双侧输卵管切除术在墨西哥妇科医生样本中的概念。住院医生应该接受哪些培训?
IF 0.1 Q4 Medicine Pub Date : 2023-07-01 DOI: 10.1016/j.gine.2023.100878
J.C. Tirado-Tapia , E. Sanchez-Valdivieso

Background

Ovarian cancer is the fifth deadliest cancer among women. There is no effective screening method. It has been suggested that ovarian cancer originates from precursor lesions in the fimbriae of the fallopian tubes.

Objective

The aim of this study was to determine the level of knowledge of opportunistic bilateral salpingectomy by gynecologists.

Methods

A cross-sectional study was carried out and a survey was sent electronically to gynecologists and gynecology residents. Demographic characteristics as well as questions of interest related to clinical practice and indication for surgery were included.

Results

52 subjects were included, 21 women and 31 men, with a mean age of 40.7 years. Thirty-five board certified gynecologists, as well as 17 gynecology residents, were included as part of the total survey group. Thirty-six individuals (69.2%) reported performing elective salpingectomy. The motivation they had to perform salpingectomy as a method of sterilization was: “reduction in the risk of ovarian cancer in the future” (55.6%). The indication for elective salpingectomy while performing other procedures was: “to prevent ovarian cancer” (61.1%). Certified gynecologists (42.9%) as well as residents (41.1%) considered “transvaginal ultrasound screening” as the best primary prevention method for ovarian cancer in low-risk women.

Conclusions

Opportunistic bilateral salpingectomy is safe and cost-effective. However, when gynecologists are interviewed to find out their level of knowledge, there is poor acceptance of opportunistic bilateral salpingectomy in Mexico. A training strategy should be designed in the gynecology residency in order to motivate ovarian cancer prevention.

背景癌症是癌症中死亡人数第五的女性。没有有效的筛选方法。有人认为癌症起源于输卵管菌毛的前驱病变。目的本研究的目的是确定妇科医生对机会性双侧输卵管切除术的认识水平。方法进行横断面研究,并以电子方式向妇科医生和妇科住院医师发送调查。包括人口统计学特征以及与临床实践和手术指征相关的感兴趣的问题。结果52名受试者,女性21名,男性31名,平均年龄40.7岁。35名获得委员会认证的妇科医生以及17名妇科住院医生被纳入总调查组。36名患者(69.2%)报告进行了选择性输卵管切除术。他们进行输卵管切除术作为一种绝育方法的动机是:“降低未来患卵巢癌症的风险”(55.6%)。在进行其他手术的同时进行选择性输卵管切除手术的指征是:“预防卵巢癌症”(61.1%)。注册妇科医生(42.9%)和居民(41.1%)认为“经阴道超声筛查”是最佳选择低风险女性癌症的初步预防方法。结论选择性双侧输卵管切除术安全、经济。然而,当妇科医生接受采访以了解他们的知识水平时,墨西哥对机会性双侧输卵管切除术的接受度很低。应在妇科住院医师中制定培训策略,以促进卵巢癌症的预防。
{"title":"Concept of opportunistic bilateral salpingectomy in a sample of Mexican gynecologists. What should residents be trained on?","authors":"J.C. Tirado-Tapia ,&nbsp;E. Sanchez-Valdivieso","doi":"10.1016/j.gine.2023.100878","DOIUrl":"https://doi.org/10.1016/j.gine.2023.100878","url":null,"abstract":"<div><h3>Background</h3><p>Ovarian cancer is the fifth deadliest cancer among women. There is no effective screening method. It has been suggested that ovarian cancer originates from precursor lesions in the fimbriae of the fallopian tubes.</p></div><div><h3>Objective</h3><p>The aim of this study was to determine the level of knowledge of opportunistic bilateral salpingectomy by gynecologists.</p></div><div><h3>Methods</h3><p>A cross-sectional study was carried out and a survey was sent electronically to gynecologists and gynecology residents. Demographic characteristics as well as questions of interest related to clinical practice and indication for surgery were included.</p></div><div><h3>Results</h3><p>52 subjects were included, 21 women and 31 men, with a mean age of 40.7 years. Thirty-five board certified gynecologists, as well as 17 gynecology residents, were included as part of the total survey group. Thirty-six individuals (69.2%) reported performing elective salpingectomy. The motivation they had to perform salpingectomy as a method of sterilization was: “reduction in the risk of ovarian cancer in the future” (55.6%). The indication for elective salpingectomy while performing other procedures was: “to prevent ovarian cancer” (61.1%). Certified gynecologists (42.9%) as well as residents (41.1%) considered “transvaginal ultrasound screening” as the best primary prevention method for ovarian cancer in low-risk women.</p></div><div><h3>Conclusions</h3><p>Opportunistic bilateral salpingectomy is safe and cost-effective. However, when gynecologists are interviewed to find out their level of knowledge, there is poor acceptance of opportunistic bilateral salpingectomy in Mexico. A training strategy should be designed in the gynecology residency in order to motivate ovarian cancer prevention.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49870198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinica e Investigacion en Ginecologia y Obstetricia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1